Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
SSR Mining
SSRM
$6.49B
| $20.9M | 0.03% |
3,003,326
-860,252
| -22% | -$5.35M |
|
652
Kearny Financial
KRNY
$604M
| $20.9M | 0.03% |
2,951,686
-284,000
| -9% | -$2.14M |
|
653
NRG Energy
NRG
$25.2B
| $20.9M | 0.03% |
231,516
-268,200
| -54% | -$24.8M |
|
654
Sensata Technologies
ST
$6.61B
| $20.6M | 0.03% |
753,600
+264,400
| +54% | +$8.59M |
|
655
First Majestic Silver
AG
$9.26B
| $20.6M | 0.03% |
3,759,181
+3,382,443
| +898% | +$21.8M |
|
656
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $20.6M | 0.03% |
814,800
-155,255
| -16% | -$3.96M |
|
657
APi Group
APG
$18.8B
| $20.4M | 0.03% |
852,150
-51,000
| -6% | -$1.21M |
|
658
TPG
TPG
$8.86B
| $20.4M | 0.03% |
324,566
-70,834
| -18% | -$4.65M |
|
659
American Public Education
APEI
$828M
| $20.4M | 0.03% |
944,720
-23,402
| -2% | -$421K |
|
660
Brink's
BCO
$4.72B
| $20.4M | 0.03% |
219,532
-19,100
| -8% | -$1.91M |
|
661
Boston Beer
SAM
$1.9B
| $20.4M | 0.03% |
67,879
-4,400
| -6% | -$1.33M |
|
662
VanEck Semiconductor ETF
SMH
$72.5B
| $20.3M | 0.03% |
+83,967
| New | +$20.8M |
|
663
Omnicell
OMCL
$1.72B
| $20.3M | 0.03% |
456,343
+201,831
| +79% | +$9.07M |
|
664
TIM SA
TIMB
$8.27B
| $20.2M | 0.03% |
1,718,588
+283,002
| +20% | +$3.97M |
|
665
Strategic Education
STRA
$1.86B
| $20.2M | 0.03% |
215,818
-9,220
| -4% | -$861K |
|
666
VF Corp
VFC
$5.79B
| $20M | 0.03% |
931,500
+771,900
| +484% | +$15.7M |
|
667
Infosys
INFY
$50.3B
| $20M | 0.03% |
+911,700
| New | +$20.4M |
|
668
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12.1B
| $20M | 0.03% |
851,200
+534,700
| +169% | +$12.7M |
|
669
Alignment Healthcare
ALHC
$2.79B
| $19.9M | 0.03% |
1,769,500
+235,000
| +15% | +$2.75M |
|
670
Chubb
CB
$133B
| $19.9M | 0.03% |
+71,999
| New | +$20.4M |
|
671
National Presto Industries
NPK
$987M
| $19.9M | 0.03% |
202,000
-28,599
| -12% | -$2.3M |
|
|
FOLD
672
DELISTED
Amicus Therapeutics
FOLD
| $19.9M | 0.03% |
2,108,616
+1,339,316
| +174% | +$13.9M |
|
673
Brookfield Asset Management
BAM
$89.2B
| $19.7M | 0.03% |
363,700
-8,200
| -2% | -$443K |
|
674
Vanguard Total International Bond ETF
BNDX
$83B
| $19.7M | 0.03% |
401,800
+127,757
| +47% | +$6.39M |
|
675
Independent Bank Corp
IBCP
$854M
| $19.7M | 0.03% |
565,700
-35,200
| -6% | -$1.25M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.